Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Stroke associated with giant cell arteritis: a population-based study.

Samson M, Jacquin A, Audia S, Daubail B, Devilliers H, Petrella T, Martin L, Durier J, Besancenot JF, Lorcerie B, Giroud M, Bonnotte B, Béjot Y.

J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):216-21. doi: 10.1136/jnnp-2014-307614. Epub 2014 Apr 29.

PMID:
24780954
2.

Predictors of cerebrovascular accidents in giant cell arteritis in a defined population.

Pego-Reigosa R, Garcia-Porrua C, Piñeiro A, Dierssen T, Llorca J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2004;22(6 Suppl 36):S13-7.

PMID:
15675128
3.

Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis.

Gonzalez-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I, Pego-Reigosa R, Lopez-Diaz MJ, Vazquez-Triñanes MC, Miranda-Filloy JA, Blanco R, Dierssen T, Gonzalez-Juanatey C, Llorca J.

Medicine (Baltimore). 2009 Jul;88(4):227-35. doi: 10.1097/MD.0b013e3181af4518.

4.

Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.

González-Gay MA, Garcia-Porrua C, Rivas MJ, Rodriguez-Ledo P, Llorca J.

Ann Rheum Dis. 2001 Apr;60(4):367-71.

5.

Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.

Catanoso M, Macchioni P, Boiardi L, Muratore F, Restuccia G, Cavazza A, Pipitone N, Mancuso P, Luberto F, Salvarani C.

Arthritis Care Res (Hoboken). 2017 Mar;69(3):430-438. doi: 10.1002/acr.22942.

PMID:
27214746
6.

Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study.

Amiri N, De Vera M, Choi HK, Sayre EC, Avina-Zubieta JA.

Rheumatology (Oxford). 2016 Jan;55(1):33-40. doi: 10.1093/rheumatology/kev262. Epub 2015 Aug 5.

PMID:
26248811
7.

Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.

Mohammad AJ, Englund M, Turesson C, Tomasson G, Merkel PA.

J Rheumatol. 2017 Jan;44(1):84-90. doi: 10.3899/jrheum.160249. Epub 2016 Nov 1.

PMID:
27803140
8.

Epidemiology of biopsy-proven giant cell arteritis (GCA).

Nordborg E, Bengtsson BA.

J Intern Med. 1990 Apr;227(4):233-6.

PMID:
2324677
9.

Giant Cell Arteritis-related Stroke: A Retrospective Multicenter Case-control Study.

de Boysson H, Liozon E, Larivière D, Samson M, Parienti JJ, Boutemy J, Maigné G, Martin Silva N, Ly K, Touzé E, Bonnotte B, Aouba A, Sacré K, Bienvenu B.

J Rheumatol. 2017 Mar;44(3):297-303. doi: 10.3899/jrheum.161033. Epub 2017 Jan 15.

PMID:
28089985
10.

Influence of age, sex, and place of residence on clinical expression of giant cell arteritis in northwest Spain.

Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J.

J Rheumatol. 2003 Jul;30(7):1548-51.

PMID:
12858456
11.

Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36 patients.

Assie C, Janvresse A, Plissonnier D, Levesque H, Marie I.

Medicine (Baltimore). 2011 Jan;90(1):40-51. doi: 10.1097/MD.0b013e318206af16.

12.

Epidemiology of biopsy-proven giant cell arteritis in South Australia.

Dunstan E, Lester SL, Rischmueller M, Dodd T, Black R, Ahern M, Cleland LG, Roberts-Thomson P, Hill CL.

Intern Med J. 2014 Jan;44(1):32-9. doi: 10.1111/imj.12293.

PMID:
24118799
13.

Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.

Li L, Neogi T, Jick S.

Rheumatology (Oxford). 2017 May 1;56(5):753-762. doi: 10.1093/rheumatology/kew482.

PMID:
28077689
14.

The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population.

Nordborg C, Johansson H, Petursdottir V, Nordborg E.

Rheumatology (Oxford). 2003 Apr;42(4):549-52.

PMID:
12649402
15.

Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study.

Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, Perez-Alvarez R, Gonzalez-Juanatey C, Sanchez-Andrade A, Martin J, Llorca J.

Medicine (Baltimore). 2007 Mar;86(2):61-8.

16.

Inpatient complications in patients with giant cell arteritis: decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency.

Unizony S, Menendez ME, Rastalsky N, Stone JH.

Rheumatology (Oxford). 2015 Aug;54(8):1360-8. doi: 10.1093/rheumatology/keu483. Epub 2015 Feb 9.

PMID:
25667435
17.

Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study.

Tomasson G, Peloquin C, Mohammad A, Love TJ, Zhang Y, Choi HK, Merkel PA.

Ann Intern Med. 2014 Jan 21;160(2):73-80.

18.

Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study.

Lo Gullo A, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Saitta A, Salvarani C, Matteson EL, Warrington KJ.

PLoS One. 2016 Feb 22;11(2):e0149579. doi: 10.1371/journal.pone.0149579. eCollection 2016.

19.

Extra- and intracranial cerebral vasculitis in giant cell arteritis: an observational study.

Larivière D, Sacre K, Klein I, Hyafil F, Choudat L, Chauveheid MP, Papo T.

Medicine (Baltimore). 2014 Dec;93(28):e265. doi: 10.1097/MD.0000000000000265. Erratum in: Medicine (Baltimore). 2015 Jan;94(1):1.

20.

Cancer preceding giant cell arteritis: a case-control study.

Kermani TA, Schäfer VS, Crowson CS, Hunder GG, Ytterberg SR, Matteson EL, Gabriel SE, Warrington KJ.

Arthritis Rheum. 2010 Jun;62(6):1763-9. doi: 10.1002/art.27429.

Supplemental Content

Support Center